These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28214385)

  • 1. Temporal changes in physiology and haematology in response to high- and micro-doses of recombinant human erythropoietin.
    Clark B; Woolford SM; Eastwood A; Sharpe K; Barnes PG; Gore CJ
    Drug Test Anal; 2017 Oct; 9(10):1561-1571. PubMed ID: 28214385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.
    Wang G; Durussel J; Shurlock J; Mooses M; Fuku N; Bruinvels G; Pedlar C; Burden R; Murray A; Yee B; Keenan A; McClure JD; Sottas PE; Pitsiladis YP
    BMC Genomics; 2017 Nov; 18(Suppl 8):817. PubMed ID: 29143667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of erythropoietin misuse by the Athlete Biological Passport combined with reticulocyte percentage.
    Bejder J; Aachmann-Andersen NJ; Bonne TC; Olsen NV; Nordsborg NB
    Drug Test Anal; 2016 Oct; 8(10):1049-1055. PubMed ID: 27696774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The research of hemoglobin mass on athletic biological passport for blood doping detection].
    Wang J; Zhang ML; Wang SL; Liu M; Yannis P
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun; 34(6):519-523. PubMed ID: 31032586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.
    Heuberger JAAC; van Eenoo P; Rotmans JI; Gal P; Stuurman FE; Post TE; Daniels JMA; Ram H; de Hon O; Burggraaf J; Cohen AF
    Drug Test Anal; 2019 Sep; 11(9):1290-1301. PubMed ID: 31232530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose exogenous erythropoietin elicits an ergogenic effect in standardbred horses.
    McKeever KH; Agans JM; Geiser S; Lorimer PJ; Maylin GA
    Equine Vet J Suppl; 2006 Aug; (36):233-8. PubMed ID: 17402424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhydration using different hydration agents does not affect the haematological markers of the athlete biological passport in euhydrated volunteers.
    Athanasiadou I; Christian Voss S; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
    J Sports Sci; 2020 Aug; 38(16):1924-1932. PubMed ID: 32543279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.
    Heuberger JAAC; Rotmans JI; Gal P; Stuurman FE; van 't Westende J; Post TE; Daniels JMA; Moerland M; van Veldhoven PLJ; de Kam ML; Ram H; de Hon O; Posthuma JJ; Burggraaf J; Cohen AF
    Lancet Haematol; 2017 Aug; 4(8):e374-e386. PubMed ID: 28669689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control.
    Souillard A; Audran M; Bressolle F; Gareau R; Duvallet A; Chanal JL
    Br J Clin Pharmacol; 1996 Sep; 42(3):355-64. PubMed ID: 8877027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of erythropoietin abuse on exercise performance.
    Sgrò P; Sansone M; Sansone A; Romanelli F; Di Luigi L
    Phys Sportsmed; 2018 Feb; 46(1):105-115. PubMed ID: 29113535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.
    Durussel J; Daskalaki E; Anderson M; Chatterji T; Wondimu DH; Padmanabhan N; Patel RK; McClure JD; Pitsiladis YP
    PLoS One; 2013; 8(2):e56151. PubMed ID: 23418527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
    Ashenden M; Gough CE; Garnham A; Gore CJ; Sharpe K
    Eur J Appl Physiol; 2011 Sep; 111(9):2307-14. PubMed ID: 21336951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclists.
    Birkhoff WAJ; Heuberger JAAC; Post TE; Gal P; Stuurman FE; Burggraaf J; Cohen AF
    Physiol Rep; 2018 Dec; 6(24):e13924. PubMed ID: 30592183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies.
    Durussel J; Haile DW; Mooses K; Daskalaki E; Beattie W; Mooses M; Mekonen W; Ongaro N; Anjila E; Patel RK; Padmanabhan N; McBride MW; McClure JD; Pitsiladis YP
    Physiol Genomics; 2016 Mar; 48(3):202-9. PubMed ID: 26757800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport.
    Bornø A; Aachmann-Andersen NJ; Munch-Andersen T; Hulston CJ; Lundby C
    Eur J Appl Physiol; 2010 Jun; 109(3):537-43. PubMed ID: 20127125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of EPO on Blood Parameters and Running Performance in Kenyan Athletes.
    Haile DW; Durussel J; Mekonen W; Ongaro N; Anjila E; Mooses M; Daskalaki E; Mooses K; McClure JD; Sutehall S; Pitsiladis YP
    Med Sci Sports Exerc; 2019 Feb; 51(2):299-307. PubMed ID: 30188362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhydration Effect on Pharmacokinetic Parameters and Detection Sensitivity of Recombinant Human Erythropoietin in Urine and Serum Doping Control Analysis of Males.
    Athanasiadou I; Dokoumetzidis A; Voss SC; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
    J Pharm Sci; 2019 Jun; 108(6):2162-2172. PubMed ID: 30684541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin as a potential biomarker for blood doping.
    Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
    Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
    Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.